Anti-VEGF protein compositions and methods for producing the same
US11098311B2 · kind B2 · utility
2Cited by
66References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 18, 2020 |
| Grant date | Aug 24, 2021 |
| Priority date | — |
| Expiry date | Aug 18, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2030/027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure pertains to compositions comprising aflibercept and methods for producing such compositions in chemically defined media and using chromatography to reduce amounts of certain aflibercept variants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.